Difference between revisions of "Nortriptyline-venlafaxine"
From Psychiatrienet
Line 3: | Line 3: | ||
| to = venlafaxine | | to = venlafaxine | ||
| stop = | | stop = | ||
− | + | {{downNortriptyline}} | |
− | |||
− | |||
| start = | | start = | ||
* '''Day 1:''' simultaneously start administration of venlafaxine in a normal dosage of 75 mg/day. | * '''Day 1:''' simultaneously start administration of venlafaxine in a normal dosage of 75 mg/day. | ||
Line 11: | Line 9: | ||
| info = | | info = | ||
* Occurrence of serotonin syndrome is theoretically (not very likely) possible, so caution is necessary. | * Occurrence of serotonin syndrome is theoretically (not very likely) possible, so caution is necessary. | ||
− | |||
}} | }} |
Revision as of 14:21, 2 November 2015
| ||||||||||||||||||||||
|
Switch medication from nortriptyline to venlafaxine.[1] [2]
- Day 1: reduce dosage to 50%.
- Day 8: stop
- Day 1: simultaneously start administration of venlafaxine in a normal dosage of 75 mg/day.
- Day 8: stop administration of nortriptyline and continue administration of venlafaxine.
- Occurrence of serotonin syndrome is theoretically (not very likely) possible, so caution is necessary.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.